Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Gore, M Szczylik, C Porta, C Bracarda, S Bjarnason, G Oudard, S Lee, S Haanen, J Castellano, D Vrdoljak, E
Gore, M
Szczylik, C
Porta, C
Bracarda, S
Bjarnason, G
Oudard, S
Lee, S
Haanen, J
Castellano, D
Vrdoljak, E
Citations
Altmetric:
Abstract
We report final results with extended follow-up from a global, expanded-access trial that pre-regulatory approval provided sunitinib to metastatic renal cell carcinoma (mRCC) patients, ineligible for registration-directed trials.
Affiliation
Description
Date
2015-06-30
Publisher
Collections
Keywords
Type
Article
Citation
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma. 2015, 113 (1):12-9 Br J Cancer